Loading…
Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia
Saved in:
| Published in: | Leukemia & lymphoma 2017-02, Vol.58 (2), p.473-474 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c333t-62a444213525223b83145006f287a3992ec03dd79fcaca01c4ef7c555345bef33 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c333t-62a444213525223b83145006f287a3992ec03dd79fcaca01c4ef7c555345bef33 |
| container_end_page | 474 |
| container_issue | 2 |
| container_start_page | 473 |
| container_title | Leukemia & lymphoma |
| container_volume | 58 |
| creator | Vatel, Orlane Aumont, Cedric Mathy, Vincent Petit, Morgane Feriel, Joffrey Sloma, Ivan Bennaceur-Griscelli, Annelise Turhan, Ali G. |
| description | |
| doi_str_mv | 10.1080/10428194.2016.1201575 |
| format | article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_10428194_2016_1201575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>27389710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-62a444213525223b83145006f287a3992ec03dd79fcaca01c4ef7c555345bef33</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwCSAvYZHiZx47UFseUiUkCmvLcRxqSOLITlTl73HUliWbmdHo3jujA8A1RnOMUnSPESMpzticIBzPcag84SdgihHJIsIQPR1nRqJRNAEX3n8jhHgWk3MwIQlNswSjKaiXrv-CTkvVGdvAnem2UFtvGttuTWUklE0B_eA7XRsVhrrtbO3h7fJ9tdncQdMUvdIFzAdoatmZxuRhB9XW2Sbo60FX1hSw0v1PCJCX4KyUlddXhz4Dn0-rj8VLtH57fl08riNFKe2imEjGGMGUE04IzVOKGUcoLkmaSJplRCtEiyLJSiWVRFgxXSaKc04Zz3VJ6Qzwfa5y1nunS9G68J8bBEZixCeO-MSITxzwBd_N3tf2ea2LP9eRVxA87AWmKa2r5c66qhCdHCrrSicbZbyg_9_4BZgAfy4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Vatel, Orlane ; Aumont, Cedric ; Mathy, Vincent ; Petit, Morgane ; Feriel, Joffrey ; Sloma, Ivan ; Bennaceur-Griscelli, Annelise ; Turhan, Ali G.</creator><creatorcontrib>Vatel, Orlane ; Aumont, Cedric ; Mathy, Vincent ; Petit, Morgane ; Feriel, Joffrey ; Sloma, Ivan ; Bennaceur-Griscelli, Annelise ; Turhan, Ali G.</creatorcontrib><identifier>ISSN: 1042-8194</identifier><identifier>EISSN: 1029-2403</identifier><identifier>DOI: 10.1080/10428194.2016.1201575</identifier><identifier>PMID: 27389710</identifier><language>eng</language><publisher>United States: Taylor & Francis</publisher><subject>Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Blood Cell Count ; Drug Hypersensitivity Syndrome - diagnosis ; Drug Hypersensitivity Syndrome - etiology ; Drug Substitution ; Fusion Proteins, bcr-abl - genetics ; Humans ; Imatinib Mesylate - adverse effects ; Imatinib Mesylate - therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics ; Male ; Middle Aged ; Protein Kinase Inhibitors - adverse effects ; Protein Kinase Inhibitors - therapeutic use ; Skin - pathology ; Treatment Outcome</subject><ispartof>Leukemia & lymphoma, 2017-02, Vol.58 (2), p.473-474</ispartof><rights>2016 Informa UK Limited, trading as Taylor & Francis Group. 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-62a444213525223b83145006f287a3992ec03dd79fcaca01c4ef7c555345bef33</citedby><cites>FETCH-LOGICAL-c333t-62a444213525223b83145006f287a3992ec03dd79fcaca01c4ef7c555345bef33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27389710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vatel, Orlane</creatorcontrib><creatorcontrib>Aumont, Cedric</creatorcontrib><creatorcontrib>Mathy, Vincent</creatorcontrib><creatorcontrib>Petit, Morgane</creatorcontrib><creatorcontrib>Feriel, Joffrey</creatorcontrib><creatorcontrib>Sloma, Ivan</creatorcontrib><creatorcontrib>Bennaceur-Griscelli, Annelise</creatorcontrib><creatorcontrib>Turhan, Ali G.</creatorcontrib><title>Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia</title><title>Leukemia & lymphoma</title><addtitle>Leuk Lymphoma</addtitle><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Blood Cell Count</subject><subject>Drug Hypersensitivity Syndrome - diagnosis</subject><subject>Drug Hypersensitivity Syndrome - etiology</subject><subject>Drug Substitution</subject><subject>Fusion Proteins, bcr-abl - genetics</subject><subject>Humans</subject><subject>Imatinib Mesylate - adverse effects</subject><subject>Imatinib Mesylate - therapeutic use</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Protein Kinase Inhibitors - adverse effects</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Skin - pathology</subject><subject>Treatment Outcome</subject><issn>1042-8194</issn><issn>1029-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EoqXwCSAvYZHiZx47UFseUiUkCmvLcRxqSOLITlTl73HUliWbmdHo3jujA8A1RnOMUnSPESMpzticIBzPcag84SdgihHJIsIQPR1nRqJRNAEX3n8jhHgWk3MwIQlNswSjKaiXrv-CTkvVGdvAnem2UFtvGttuTWUklE0B_eA7XRsVhrrtbO3h7fJ9tdncQdMUvdIFzAdoatmZxuRhB9XW2Sbo60FX1hSw0v1PCJCX4KyUlddXhz4Dn0-rj8VLtH57fl08riNFKe2imEjGGMGUE04IzVOKGUcoLkmaSJplRCtEiyLJSiWVRFgxXSaKc04Zz3VJ6Qzwfa5y1nunS9G68J8bBEZixCeO-MSITxzwBd_N3tf2ea2LP9eRVxA87AWmKa2r5c66qhCdHCrrSicbZbyg_9_4BZgAfy4</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Vatel, Orlane</creator><creator>Aumont, Cedric</creator><creator>Mathy, Vincent</creator><creator>Petit, Morgane</creator><creator>Feriel, Joffrey</creator><creator>Sloma, Ivan</creator><creator>Bennaceur-Griscelli, Annelise</creator><creator>Turhan, Ali G.</creator><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20170201</creationdate><title>Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia</title><author>Vatel, Orlane ; Aumont, Cedric ; Mathy, Vincent ; Petit, Morgane ; Feriel, Joffrey ; Sloma, Ivan ; Bennaceur-Griscelli, Annelise ; Turhan, Ali G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-62a444213525223b83145006f287a3992ec03dd79fcaca01c4ef7c555345bef33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Blood Cell Count</topic><topic>Drug Hypersensitivity Syndrome - diagnosis</topic><topic>Drug Hypersensitivity Syndrome - etiology</topic><topic>Drug Substitution</topic><topic>Fusion Proteins, bcr-abl - genetics</topic><topic>Humans</topic><topic>Imatinib Mesylate - adverse effects</topic><topic>Imatinib Mesylate - therapeutic use</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Protein Kinase Inhibitors - adverse effects</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Skin - pathology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vatel, Orlane</creatorcontrib><creatorcontrib>Aumont, Cedric</creatorcontrib><creatorcontrib>Mathy, Vincent</creatorcontrib><creatorcontrib>Petit, Morgane</creatorcontrib><creatorcontrib>Feriel, Joffrey</creatorcontrib><creatorcontrib>Sloma, Ivan</creatorcontrib><creatorcontrib>Bennaceur-Griscelli, Annelise</creatorcontrib><creatorcontrib>Turhan, Ali G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Leukemia & lymphoma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vatel, Orlane</au><au>Aumont, Cedric</au><au>Mathy, Vincent</au><au>Petit, Morgane</au><au>Feriel, Joffrey</au><au>Sloma, Ivan</au><au>Bennaceur-Griscelli, Annelise</au><au>Turhan, Ali G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia</atitle><jtitle>Leukemia & lymphoma</jtitle><addtitle>Leuk Lymphoma</addtitle><date>2017-02-01</date><risdate>2017</risdate><volume>58</volume><issue>2</issue><spage>473</spage><epage>474</epage><pages>473-474</pages><issn>1042-8194</issn><eissn>1029-2403</eissn><cop>United States</cop><pub>Taylor & Francis</pub><pmid>27389710</pmid><doi>10.1080/10428194.2016.1201575</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1042-8194 |
| ispartof | Leukemia & lymphoma, 2017-02, Vol.58 (2), p.473-474 |
| issn | 1042-8194 1029-2403 |
| language | eng |
| recordid | cdi_crossref_primary_10_1080_10428194_2016_1201575 |
| source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
| subjects | Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Blood Cell Count Drug Hypersensitivity Syndrome - diagnosis Drug Hypersensitivity Syndrome - etiology Drug Substitution Fusion Proteins, bcr-abl - genetics Humans Imatinib Mesylate - adverse effects Imatinib Mesylate - therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Male Middle Aged Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - therapeutic use Skin - pathology Treatment Outcome |
| title | Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T13%3A38%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%20reaction%20with%20eosinophilia%20and%20systemic%20symptoms%20(DRESS)%20induced%20by%20imatinib%20in%20chronic%20myeloid%20leukemia&rft.jtitle=Leukemia%20&%20lymphoma&rft.au=Vatel,%20Orlane&rft.date=2017-02-01&rft.volume=58&rft.issue=2&rft.spage=473&rft.epage=474&rft.pages=473-474&rft.issn=1042-8194&rft.eissn=1029-2403&rft_id=info:doi/10.1080/10428194.2016.1201575&rft_dat=%3Cpubmed_cross%3E27389710%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c333t-62a444213525223b83145006f287a3992ec03dd79fcaca01c4ef7c555345bef33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/27389710&rfr_iscdi=true |